359 related articles for article (PubMed ID: 23192888)
21. Bioavailability of indomethacin-saccharin cocrystals.
Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
[TBL] [Abstract][Full Text] [Related]
22. The role of cocrystals in pharmaceutical science.
Shan N; Zaworotko MJ
Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceutical cocrystals: a novel approach for oral bioavailability enhancement of drugs.
Chadha R; Saini A; Arora P; Bhandari S
Crit Rev Ther Drug Carrier Syst; 2012; 29(3):183-218. PubMed ID: 22577957
[TBL] [Abstract][Full Text] [Related]
24. Novel furosemide cocrystals and selection of high solubility drug forms.
Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
[TBL] [Abstract][Full Text] [Related]
25. Challenges in Translational Development of Pharmaceutical Cocrystals.
Kale DP; Zode SS; Bansal AK
J Pharm Sci; 2017 Feb; 106(2):457-470. PubMed ID: 27914793
[TBL] [Abstract][Full Text] [Related]
26. Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies.
Ross SA; Lamprou DA; Douroumis D
Chem Commun (Camb); 2016 Jul; 52(57):8772-86. PubMed ID: 27302311
[TBL] [Abstract][Full Text] [Related]
27. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
Loschen C; Klamt A
J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
[TBL] [Abstract][Full Text] [Related]
28. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.
Kuminek G; Cao F; Bahia de Oliveira da Rocha A; Gonçalves Cardoso S; Rodríguez-Hornedo N
Adv Drug Deliv Rev; 2016 Jun; 101():143-166. PubMed ID: 27137109
[TBL] [Abstract][Full Text] [Related]
29. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
Elder DP; Holm R; Diego HL
Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical cocrystals: along the path to improved medicines.
Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
[TBL] [Abstract][Full Text] [Related]
32. Themed issue: improve dissolution, solubility and bioavailability of poorly soluble drugs.
Perrie Y; Rades T
J Pharm Pharmacol; 2010 Nov; 62(11):1517-8. PubMed ID: 21039536
[No Abstract] [Full Text] [Related]
33. Recent Advances in Pharmaceutical Cocrystals: A Focused Review of Flavonoid Cocrystals.
Xu J; Shi Q; Wang Y; Wang Y; Xin J; Cheng J; Li F
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677670
[TBL] [Abstract][Full Text] [Related]
34. Pharmaceutical cocrystals: a rising star in drug delivery applications.
Panzade P; Wagh A; Harale P; Bhilwade S
J Drug Target; 2024 Dec; 32(2):115-127. PubMed ID: 38164658
[TBL] [Abstract][Full Text] [Related]
35. Amorphous solid dispersions: a robust platform to address bioavailability challenges.
Newman A; Nagapudi K; Wenslow R
Ther Deliv; 2015 Feb; 6(2):247-61. PubMed ID: 25690090
[TBL] [Abstract][Full Text] [Related]
36. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.
Cerreia Vioglio P; Chierotti MR; Gobetto R
Adv Drug Deliv Rev; 2017 Aug; 117():86-110. PubMed ID: 28687273
[TBL] [Abstract][Full Text] [Related]
37. Mechanochemical Approaches to Pharmaceutical Cocrystal Formation and Stability Analysis.
Lin SY
Curr Pharm Des; 2016; 22(32):5001-5018. PubMed ID: 27464722
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical properties of two ethenzamide-gentisic acid cocrystal polymorphs: Drug release profiles, spectroscopic studies and theoretical calculations.
Sokal A; Pindelska E; Szeleszczuk L; Kolodziejski W
Int J Pharm; 2017 Apr; 522(1-2):80-89. PubMed ID: 28274662
[TBL] [Abstract][Full Text] [Related]
39. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
Manchanda D; Kumar A; Nanda A
Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
[TBL] [Abstract][Full Text] [Related]
40. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.
Srivastava D; Fatima Z; Kaur CD
Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
